Deutsche Bank
AVBP icon

Deutsche Bank’s ArriVent BioPharma AVBP Stock Holding History

Deutsche Bank’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
39,180
+11,201
+40% +$331K ﹤0.01% 2143
2026
Q1 		$645K Buy
27,979
+6,448
+30% +$146K ﹤0.01% 2443
2025
Q4 		$433K Buy
21,531
+1,559
+8% +$32.5K ﹤0.01% 2649
2025
Q3 		$368K Buy
19,972
+2,392
+14% +$47K ﹤0.01% 2709
2025
Q2 		$383K Sell
17,580
-5,603
-24% -$116K ﹤0.01% 2593
2025
Q1 		$429K Sell
23,183
-953
-4% -$23.3K ﹤0.01% 2562
2024
Q4 		$643K Buy
24,136
+8,805
+57% +$253K ﹤0.01% 2489
2024
Q3 		$360K Buy
+15,331
New +$348K ﹤0.01% 2637

Other funds holding AVBP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Deutsche Bank's AVBP Position: Q2 2026 in Review

Deutsche Bank increased its ArriVent BioPharma (AVBP) stake by 40% in Q2 2026, buying an estimated $331K and bringing the position to 39,180 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2143.

Deutsche Bank first reported a position in AVBP in Q3 2024 and has held it in 8 quarters since. 41 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Deutsche Bank held 39,180 shares of ArriVent BioPharma worth $1.36M as of Q2 2026.
  • Deutsche Bank bought 11,201 ArriVent BioPharma shares in Q2 2026, an estimated $331K.
  • ArriVent BioPharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2143 holding.
  • Deutsche Bank first reported a position in ArriVent BioPharma in Q3 2024 and has held it in 8 quarters since.
  • 41 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.